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Despite the increasing popularity of cardioplegic techniques there is no 
consensus as to the optimal myocardial protective technique for first-time 
or repeat coronary artery bypass grafting. Intermittent global ischemia was 
used in 159 consecutive patients (142 male; 17 female) undergoing repeat 
coronary artery bypass grafting during a 6-year period (1987 to 1992). The 
median age of the patients was 60 years (90% confidence interval: 47 to 70 
years) and the median interval from the first operation was 9 years (90% 
confidence interval: 2 to 14 years). One third of the patients required 
emergency (within 24 hours) or urgent (within 7 days) operations because 
of failure of symptoms to resolve with medical therapy. Compared with 
events at the initial operation there was an increased prevalence of 
impaired ventricular function (ejection fraction <50%) and increased use 
of the internal thoracic artery (48% versus 9%). Two of 12 patients who 
required emergency operations died in the hospital, which resulted in an 
overall mortality rate at 30 days of 1%. Intraaortic balloon pump support 
was required in five patients (3%) and cardiac dose inotropic support in 
21% of patients for up to 24 hours after operation. There was definite 
electrocardiographic evidence of infarction in 11 patients (7%). The mean 
postoperative blood loss, without aprotinin, was 627 ml (standard eviation 
327 ml) and two patients required reexploration because of bleeding. Five 
patients had a hemiparesis (3%) and a further four patients (3%) had a 
mild or transient postoperative focal neurologic deficit. The median 
postoperative hospital stay was 9 days (90% confidence interval: 7 to 20 
days) although 10% of patients required a hospital stay in excess of 21 days. 
No patient was lost to follow-up. The median (and interquartile range) 
period of follow-up was 1.6 (1 to 3) years. Eight patients died in the 
follow-up period, which resulted in an estimated survival of 80% at 5 years. 
At a mean follow-up period of 2 years (and with or without antianginal 
medication) 83% of patients had no or minimal angina, 12% had angina on 
moderate xertion, and 5% had angina on minimal exertion. In comparison 
with other current series of repeat coronary revascularization ur results 
suggest hat repeat coronary artery bypass grafting can be done with 
intermittent global ischemia with early and intermediate r sults at least 
equivalent to those obtained with cardioplegic methods. (J Thorac Cardio- 
vasc Surg 1996;112:501-7) 
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T he requirement for repeat coronary artery bypass grafting (CABG) comprises an ever-increasing 
proportion of the coronary revascularization work- 
load with the incidence increasing from 3% at 5 
years to 11% at 10 years and exceeding 17% at 12 
years. 1 There is no consensus as to the optimal 
method of myocardial protection for either first- 
time or repeat CABG. Commonly used techniques 
vary from intermittent global ischemia 2-5 to a pleth- 
ora of cardioplegic solution compositions, tem- 
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Table I. Preoperative risk factors 
No.(%) 
Unstable angina 57 (36) 
Previous myocardial infarction 102 (64) 
<1 wk 4 (3) 
1-6 wk 2 (1) 
>6 wk 96 (60) 
Hypertension (systolic blood pressure 38 (24) 
>140 mm Hg) 
Hypercholesterolemia 29 (18) 
Diabetes 23 (14) 
Previous cerebrovascular accident 6 (4) 
Morbid obesity (>150% ideal body weight) 7 (5) 
Current smoker (1-10 cigarettes/day) 20 (13) 
peratures, and methods of delivery. 6-9 Despite the 
popularity of cardioplegic techniques there are 
continuing reports of excellent clinical results 2' 3 and 
low levels of myocardial injury 4' 5 with noncardiople- 
gic techniques. Nevertheless, even proponents of 
intermittent global ischemia for first-time CABG 
advise against its use for repeat CABG. 2 
It is our practice to perform both initial and 
repeat CABG with intermittent global ischemia nd 
induced ventricular fibrillation. This paper presents 
the early and intermediate results with this tech- 
nique in 159 consecutive patients undergoing repeat 
CABG during a 6-year period. 
Patients and methods 
The case notes of all patients undergoing isolated 
repeat CABG done by one surgeon (J.E.W.) in this 
institution during a 6-year period (1987 to 1992) were 
reviewed. Patients who required concurrent procedures 
such as a valve operation or aneurysmectomy were not 
included. 
Surgical technique. The surgical technique for repeat 
operations i similar to that for first-time operations. Both 
groins are draped but the femoral vessels are not routinely 
exposed. After median sternotomy and exposure of the 
aorta, heparin is administered and the distal ascending 
aorta cannulated. The right atrium is then cannulated with 
a single atrial basket. Unless there is hemodynamic insta- 
bility, dissection continues without bypass with every effort 
being made to minimize handling of previous grafts. 
Cardiopulmonary b pass is conducted with nonpulsatile 
flow and the systemic temperature allowed to drift to 
34 ° C. No topical cooling is used. There is no routine 
direct or indirect left ventricular venting. The distal 
anastomoses are done during brief periods (approximately 
10 minutes) of aortic clamping and induced fibrillation. 
On completion of the distal anastomosis the aortic clamp 
is released and the proximal anastomosis constructed 
after a portion of the ascending aorta is isolated in a 
side-biting clamp. If the heart does not defibrillate spon- 
taneously, defibrillation is achieved with 10 to 20 joules of 
direct current. 
Electrocardiographic diagnosis of myocardial infarc- 
tion. Serial electrocardiograms (ECGs) were done rou- 
tinely within 6 hours of the operation and on the first and 
second postoperative days. Additional ECGs were done as 
indicated. A new Q wave (>0.04 msee duration) or loss of 
more than 25% R waves in at least two leads was 
considered iagnostic of infarction. Minor ST-T wave 
changes and changes in conduction were not by them- 
selves considered iagnostic of infarction. 
Follow-up. Review of follow-up outpatient clinic notes 
and direct contact of the general practitioner was made to 
determine the following: (1) whether the patient was still 
alive; (2) whether the patient still had angina and of what 
severity (0, no angina; 1, angina only on maximum exer- 
tion; 2, angina on moderate xertion; 3, angina on mini- 
mal exertion or at rest or angina that necessitated further 
hospital admission); and (3) amount of antianginal med- 
ication required (0, no medication; 1, single-drug therapy; 
2, double-drug therapy; 3, triple-drug therapy) (see ap- 
pendix). 
Statistics. Means and standard eviations are used for 
data that were normally distributed and medians and 90% 
confidence intervals for nonparametric data. Survival data 
are presented as a Kaplan-Meier survival curve with 
Greenwood confidence limits (STATA software, version 
3.1, sixth edition, Stata Corporation, College Station, 
Tex.). 
Results 
Patients. During a 6-year period (1987 to 1992) 
159 consecutive patients underwent repeat CABG 
done by one surgeon (J.E.W.). The group comprised 
142 men and 17 women. The median age of the 
patients was 60 years (90% confidence interval: 47 
to 70 years) and 5% of patients were older than 70 
years. The median interval from the first operation 
was 9 years (90% confidence interval: 2 to 14 years). 
Follow-up. No patient was lost to follow-up. The 
median (and interquartile range) period of fol- 
low-up was 1.6 (1 to 3) years. 
Preoperative risk factors. Preoperative risk fac- 
tors are summarized in Table I. Two thirds of 
patients had previously had a myocardial infarction 
(4% within the preceeding 6 weeks), one quarter 
had hypertension, one fifth had hypercholesterol- 
emia, and 14% had diabetes. Additionally 4% of 
patients were morbidly obese (>150% ideal body 
weight), 4% had had a previous cerebrovascular 
accident, and 13% were current smokers. 
Cardiac catheterization. Angiography before the 
repeat operation invariably showed severe disease 
or occlusion of previous vein grafts usually accom- 
panied by progression of native coronary artery 
disease. Almost 70% of previous grafts were totally 
occluded and of the remaining patent grafts half 
were obviously diseased (stenosis >50%). Ventricu- 
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Table II. Ventricular function as assessed by EF 
No. of patients (%) 
Initial operation Repeat operation 
Good (>50%) 119 (75) 80 (50) 
Fair (30%-49%) 32 (20) 52 (32) 
Poor (<30%) 1 (1) 21 (13) 
Missing data 7 (4) 7 (4) 
lography (Table II) revealed good ventricular func- 
tion (ejection fraction [EF] >50%) in 50% of pa- 
tients at repeat CABG compared with 75% at the 
initial operation. In contrast 32% of patients under- 
going repeat CABG had fair (EF 30% to 49%) and 
13% poor ventricular function (EF <30%) com- 
pared, respectively, with 20% and 1% at the first 
operation. Data concerning EF were missing in 4% 
of patients. 
Symptoms and urgency of operation. Ninety- 
three patients (58%) had stable angina and 57 
(36%) had unstable symptoms. Every effort was 
made to stabilize symptoms with maximal medical 
therapy including intravenous nitrates and heparin. 
Only those patients in whom this regimen failed to 
stabilize the symptoms or who could not tolerate 
withdrawal of intravenous nitrates or heparin under- 
went operation within 7 days of referral. Only 
patients with ongoing chest pain, accompanied by 
hemodynamic nstability or ECG changes, or both, 
underwent emergency operations. Consequently 107 
patients (67%) underwent elective reoperation, 40 
(25%) required urgent reoperation (between 1 and 
7 days after hospital admission), and 12 patients 
(8%) required an emergency operation (within 24 
hours of referral). 
Procedures at reoperation (Table III). A mean of 
2.6 grafts had been inserted at the initial operation 
with 9% of patients receiving an internal thoracic 
artery (ITA) graft and 18% requiring an endarter- 
ectomy. At repeat operation a mean of 2.4 grafts 
were inserted with 48% of patients receiving an ITA 
graft and 15% requiring an endarterectomy. At
repeat CABG there was a significant increase in the 
number of grafts to the circumflex system and an 
increase in the frequency of grafts to the posterior 
descending artery rather than the main right coro- 
nary artery. 
Deaths (Table IV). Two patients died within 30 
days of the operation (1%). Both were patients who 
required emergency repeat CABG. One died as a 
result of low cardiac output in the operating room 
despite the use of an intraaortic balloon pump and 
Table III. Procedure at repeat operation 
No. of patients (%) 
Initial operation Repeat operation 
Endarterectomy 29 (18) 24 (15) 
0 130 (82) 135 (85) 
1 25 (16) 22 (14) 
2 4 (3) 2 (1) 
ITA used 14 (9) 77 (48) 
0 SVG 2 (1) 9 (6) 
1 SVGs 17 (11) 38 (24) 
2 SVGs 46 (29) 76 (48) 
3 SVGs 74 (47) 30 (19) 
4 SVGs 17 (11) 5 (3) 
5 SVGs 1 (1) 0 
Missing data 2 (1) 1 (1) 
LAD graft 132 (83) 132 (83) 
Diagonal graft 42 (26) 19 (12) 
Intermediate graft 3 (2) 10 (6) 
OM graft 40 (25) 83 (52) 
RCA graft 86 (54) 65 (41) 
PDA graft 25 (16) 44 (28) 
SVG, Saphenous vein graft; LAD, left anterior descending; OM, obtuse 
marginal; RCA, right coronary artery; PDA, posterior descending artery. 
the other died of intractable ventricular fibrillation. 
A further eight patients (5%) died outside the 
hospital within the follow-up period, although it was 
not possible to establish the precise cause of death 
in the absence of autopsy examination. 
Intraaortie balloon pump. An intraaortic balloon 
pump was required in five patients (3%) to assist 
weaning from cardiopulmonary bypass. Of these 
patients one died, three required intraaortic balloon 
pump support for 3 days, and one patient required 
this support for 1 day. 
Ventilation and intensive care unit stay. Extuba- 
tion was possible in 72% of patients within 12 
hours of return to the intensive care unit (ICU) 
and in 96% within 24 hours. Discharge from the 
ICU was achieved in 79% of patients within 24 
hours, in 92% within 48 hours, and in 96% within 
72 hours. In 4% of patients the ICU stay was 
between 3 and 9 days. 
Inotropie support. Renal-dose dopamine (<5 
p~g/kg per minute) was administered routinely. Car- 
diac-dose dopamine (5 to 10/xg/kg per minute) was 
required in 15% of patients and a further 6% 
required epinephrine in the early postoperative p - 
riod. In most patients inotropic therapy was discon- 
tinued within 24 hours but 7% of patients required 
inotropic support for up to 5 days. 
Bleeding. Aprotinin was not used in any patient. 
The mean postoperative blood loss was 627 ml 
(standard deviation 327 ml). Two patients were 
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Table IV. Comparison of patient population and complications with those of other series 
Study Taggart Lytle 12 Salomon z3 Rosengart 14 Ak115 
Years of study 1987-1992 1988-1991 1970-1988 1988-1992 1981-1990 
No. of patients 159 1663 508 240 115 
Mean age at initial and repeat 52/60 53/63 56/60 55/64 NR/54 
operations (yr) 
Male patients (%) 89 85 82 85 95 
Interval between operations (yr) 8.7 9.5 7.6 9.1 7.4 
Urgent/emergency operations (%) 33 2 3 54 NR 
Good LV function (EF >50%) (%) 51 61 50 NR 75 
Use of ITA, first versus repeat 9; 48 33; 61 46; 24 15; 59 5; 63 
operation (%) 
Myocardial protection IGI (34 ° C) CC; BC a, r NR BC a, r IGI; CC a 
Core temp (°C) 34 Cold NR Cold 30 
Hospital death (%) 1 4 7 6 5 
Complication (%) 
Infarct 7 7 9 NR 4 
Stroke 4 3 2 NR 4 
Bleeding 1 4 7 NR 3 
NR, Not recorded; LV, left ventricular; IGI, intermittent global ischemia; CC, crystalloid cardioplegia; BC, blood cardioplegia; , antegrade; r, retrograde. 
returned to the operating room because of surgical 
bleeding. 
Arrhythmias. Atrial fibrillation necessitating dig- 
italization occurred in 22 patients (14%) and other 
supraventricular rythmias developed in four oth- 
ers (3%). 
Myocardial infarction. There was definite ECG 
evidence of perioperative infarction in 11 patients 
(7%). 
Cerehrovascular accident. Five patients had a 
hemiparesis (3%) and survived with a persisting 
moderate to severe deficit. Four other patients (3%) 
had minor focal neurologic deficits that resolved 
completely. 
Wound infection. Sternal dehiscence occurred in 
one patient and superficial wound infections in 13 
(8%). 
Hospital stay. The median hospital stay was 9 
days. Seventy-five percent of patients were dis- 
charged from the hospital within 12 days and 90% 
within 20 days. Nevertheless 10% of patients re- 
quired a hospital stay in excess of 3 weeks. 
Follow-up (Fig. 1). During the follow-up period 
of the study eight patients died (in addition to the 2 
operative deaths), which resulted in an estimated 
survival of 82% (95% confidence interval: 65% to 
92%) at 5 years. At most recent follow-up 59% of 
patients were free from angina, 24% had angina on 
severe xertion, 12% had angina on moderate xer- 
tion, and 5% had angina on minimal exertion or at 
rest. With regard to antianginal medication 32% of 
patients required no medication, 21% required sin- 
gle-drug therapy, 8% required two drugs, 9% re- 
quired three drugs, and 4% required four drugs 
(drug therapy data were missing in 12%). 
Discussion 
Despite its continued use in first-time CABG 
there has been no report specifically addressing the 
use of intermittent global ischemia for repeat 
CABG. Indeed, a recent review of techniques for 
myocardial protection in repeat CABG did not 
mention noncardioplegic techniques, 7 and even 
strong proponents of its use in first-time CABG 
advise against its use in repeat operations) 
Our main rationale for the use of intermittent 
global ischemia for repeat CABG is based on the 
excellent clinical results 2' 3 and low levels of myocar- 
dial injury 4' 5 obtained with its use in first-time 
CABG. In a randomized trial, with use of the highly 
specific marker cardiac troponin T to quantify myo- 
cardial injury, we demonstrated that intermittent 
global ischemia provides at least equivalent myo- 
cardial protection to that of antegrade delivery of 
cold crystalloid cardioplegic solution in first-time 
CABG. 5 It is possible that the cardioprotective 
efficacy of intermittent global ischemia may be a 
result, at least in part, of "ischemic precondition- 
ing," the phenomenon whereby a brief period of 
ischemia followed by reperfusion makes the myocar- 
dium less vulnerable to subsequent ischemic peri- 
ods) ° Ischemic preconditioning, one of the most 
powerful and reproducible ndogenous methods of 
myocardial protection, is inducible in all animal 
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Fig. 1. Kaplan-Meier survival curve with Greenwood confidence limits. 
species and has recently been demonstrated in clin- 
ical practice. u 
The major limitation of the current study is that of 
all retrospective nonrandomized studies of repeat 
CABGJ 2-15 Nevertheless, the strengths of our study 
are that it includes all patients who underwent 
repeat CABG during a 6-year period in one hospital 
done by one surgeon and that the clinical end points 
of death, ECG-confirmed myocardial infarction, 
and cerebrovascular ccident provide suitably hard 
end points to allow comparison with other studies of 
repeat  CABG.  ]2-15 In terms of age, sex distribution, 
and interval from the initial operation, our patients 
are similar to those in other current studies of 
repeat CABG (Table IV). 12-15 Our  patients were, 
however, a mean of 8 years older than those previ- 
ously undergoing repeat CABG in this hospital 16' i7 
and those reported elsewhere in the United King- 
dom. ]5 
The overall 30-day mortality rate of 1% in our 
patients is favorable in comparison with that in 
other reports in the literature (Table IV) and par- 
ticularly so considering that one third of our patients 
required urgent or emergency operations (Table 
IV). The Lwo patients who died in our series were 
among the 12 patients in the emergency group 
(17%). One major difference among the studies of 
repeat CABG is the proportion of patients who 
required an urgent or emergency operation (Table 
IV). In the largest and most recent reports from the 
Cleveland Clinic ]2 and the Oregon group, ~3 fewer 
than 3% of patients undergoing repeat CABG re- 
quired emergency or urgent operations in contrast 
to 33% of our patients and 54% of those reported by 
Rosengart and colleaguesJ 4 This presumably re- 
flects differences in referral patterns to different 
institutions rather than variance in medical manage- 
ment, inasmuch as our policy was to strenuously 
avoid reoperation i the acute situation. Only those 
patients whose symptoms could not be controlled 
with maximal medical therapy or who could not 
tolerate withdrawal of intravenous nitrates or hep- 
arin underwent operation within 7 days of referral. 
Emergency operations were reserved for patients 
with ongoing chest pain, accompanied by hemody- 
namic instability or ECG changes or both despite 
full medication. 
As with all techniques for repeat CABG the 
presence of patent but diseased vein grafts merits 
special consideration, in our population almost 70% 
of previous grafts were totally occluded and of the 
remainder approximately half had obvious disease. 
This is similar to the experience of the Harefield 
group. Is Retrograde cardioplegia has been advo- 
cated as the preferred technique for myocardial 
protection for repeat CABG because of its theoretic 
potential for reducing distal embolization from dis- 
eased grafts and improving delivery of cardioplegic 
solution beyond stenosed or occluded grafts. Claims 
that retrograde cardioplegia improves the results of 
repeat operations have, however, been largely based 
on results of nonrandomized historically controlled 
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studies. 7-9 The prevalence of ECG-confirmed peri- 
operative myocardial infarction of 7% in our study is 
similar to that in other studies of repeat CABG 
(Table IV) and even in studies by the advocates of 
retrograde cardioplegia. 7-9Indeed, the similarity of 
perioperative infarction rates in our study and in 
those in which retrograde cardioplegia was used 
suggests that perioperative infarction might be 
largely caused by dislodgement of debris from dis- 
eased but patent grafts before the institution of 
cardiopulmonary bypass. 
Of particular elevance in the preoperative risk 
factors was the deterioration in left ventricular 
function in patients having repeat CABG. The pro- 
portion of our patients with good left ventricular 
function (EF >50%) decreased from 75% at the 
initial operation to 50% at repeat operation, similar 
to that reported in other studies (Table IV). Simul- 
taneously, the proportion of our patients with poor 
left ventricular function (EF <30%) increased from 
1% at the initial operation to 12% at repeat opera- 
tion. 
The most significant difference between initial 
and repeat operations in our patients was the in- 
creased use of the ITA from 9% to 48%, respec- 
tively. Lack of use of the ITA during first-time 
CABG is now recognized to be one of the risk 
factors for necessitating repeiat CABG. 1 In our study 
only 48% of patients undergoing repeat CABG 
received an ITA graft, which is similar to the 
frequency of its use (between 46% and 63%) in 
other studies of repeat CABG. ~245 The relatively 
low use of the ITA in our patients undergoing 
repeat CABG was for two reasons: (1) ITA grafts 
were not widely used in the United Kingdom until 
their associated benefits were firmly established by 
the Cleveland Clinic in 198618 and (2) there were 
concerns about he suitability of the ITA in the one 
third of patients who required urgent or emergency 
repeat CABG. The presence of a patent ITA graft at 
repeat operation was uncommon in our study but 
did not interfere with the technique of intermittent 
global ischemia. In such situations careful dissection 
of the ITA from the surface of the heart allowed 
application of a soft bulldog clamp, if necessary, 
during the period of ischemia. As reported in the 
other studies of repeat CABG, the total number of 
grafts inserted at reoperation tends to be less than 
that in the initial operation. I215 
One major concern with intermittent global isch- 
emla is the possibility of an increased risk of cere- 
brovascular ccident because of the requirement for 
repeated clamping of the aorta during the distal 
anastomosis and isolation of a portion of ascending 
aorta in a side-biting clamp for construction of the 
proximal anastomosis. Five (3%) of our patients had 
a hemiparesis, a prevalence similar to that reported 
in other series of repeat CABG with a variety of 
cardioplegic techniques (Table IV). A further four 
patients had transient or mild focal neurologic def- 
icits, 19 which resolved completely. In one of the 
largeSt studies to date, Martin and colleagues 2° 
reported aprevalence of perioperative stroke at 3% 
(and total neurologic events at 4.5%) in 493 patients 
undergoing first-time CABG and randomized to re- 
ceive warm blood cardioplegic solution administered 
in combined antegrade and retrograde fashion. 
There are few data in the literature regarding the 
durations of postoperative ntilation, ICU and hos- 
pital stay, and, consequently, financial implications for 
repeat CABG. Even without aprotinin therapy the 
mean postoperative blood loss was 627 ml (standard 
deviation 327 ml) and only two patients required 
reexploration because of bleeding. In our Study 96% of 
patients were extubated within 24 hours of the opera- 
tion and 92% were discharged from the ICU within 48 
hours. Nevertheless, 3% of patients required intraaor- 
tic balloon pump support, approximately one fifth 
required cardiac-dose inotropic therapy, and 4% of 
patients required an ICU stay of between 3 and 9 days. 
The median hospital stay in our patients was 9 days 
compared with an average of 11 days in New York 
Hospital, 21 but 10% of our patients required ahospital 
stay in excess of 3 weeks. 
In the follow-up period there were eight deaths 
among our patients, which gave an estimated 5-year 
survival of approximately 80%. Even after repeat 
operation the most important influence on longevity 
is ventricular function and our 5-year survival is 
similar to that reported by Salomon and col- 
leagues 13 for patients with an EF of 41% to 60%. 
It is estimated that the recurrence of angina fter 
repeat operations is almost double that of the 
first-time operation. 21 Lytle and colleagues 22 re- 
ported that 50% of patients were free from angina 5 
years after repeat operations. Although our results 
compare favorably, because 83% of patients were 
free from angina at a mean follow-up period of 4 
years, 46% of patients required between two and 
four drugs as antianginal medication. However, at a 
mean follow-up period of 2 years, 12% of our 
patients had angina on moderate xertion and 5% 
had angina on minimal exertion, which confirms the 
palliative nature of repeat operations. 
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In summary, our results demonstrate  that repeat  
coronary revascuiar izat ion can be done with inter- 
mittent global ischemia with little mortal i ty and 
acceptable short - term results at least as favorable 
as those repor ted with cardioplegic techniques. 
Whether  ret rograde cardioplegic techniques, as cur- 
rently advocated, would lead to a reduct ion in 
mortal i ty and morbidi ty would require a prospec-  
tive, randomized clinical trial. 
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Appendix 
Questionnaire to general practitioner: 
Is your patient alive or dead? 
If dead, when and how did he/she die? 
When did you last see your patient? 
Does your patient have angina? 
If yes, what is his/her functional class? 
1. No limitation of physical activity. Ordinary physi- 
cal activity does not cause undue fatigue, palpita- 
tion, dyspnea, or angina. 
2. Slight limitation of physical activity. Comfortable 
at rest but ordinary physical activity results in 
fatigue, palpitation, dyspnea, or angina. 
3. Marked limitation of physical activity. Comfort- 
able at rest but less than ordinary physical activity 
causes fatigue, palpitation, dyspnea, or angina. 
4. Inability to carry on any physical activity without 
discomfort. Symptoms of cardiac inSuificiency or 
angina may be present even at rest. If any physical 
activity is undertaken, discomfort is increased. 
Is your patient receiving antianginal medication? 
If yes, what is it? 
Has the patient had an ECG stress test or a cardiac 
catheterization since the operation? 
If yes, do you know the result? 
